Deals Pipeline
Your Business is in Excellent Health
Strong profitability, healthy leverage, and growing revenue demonstrate a well-managed business. Key areas like liquidity and debt management are well above industry benchmarks. Minor attention needed on operational efficiency.
Financial Stability
Profitability
Liquidity
Operational Efficiency
Growth Trajectory
Health Score Trend
All 5 categories over 8 quarters
Category Comparison
Current health scores by category
Financial Stability
Strong balance sheet with healthy debt levels
Debt-to-Equity Ratio
Well below industry avg of 1.0x
Interest Coverage
Far exceeds 3x minimum threshold
Equity Ratio
Strong ownership position
Fixed Charge Coverage
Comfortable margin
Profitability
Above-average margins with improving trends
Gross Profit Margin
Industry-leading margin
Net Profit Margin
Beats benchmark of 12.5%
Return on Equity
Exceptional shareholder returns
Return on Assets
Efficient asset utilization
Liquidity
Excellent short-term financial health
Current Ratio
Strong short-term coverage
Quick Ratio
Excludes inventory — still strong
Cash Ratio
Sufficient cash reserves
Working Capital
Growing steadily QoQ
Operational Efficiency
Good efficiency with room for inventory optimization
Asset Turnover
Above industry average
Inventory Turnover
Improving from 5.52x
Days Sales Outstanding
Fast collection cycle
Days Payable Outstanding
Balanced supplier terms
Growth Trajectory
Consistent double-digit revenue growth
Revenue Growth (YoY)
Accelerating from 11.8%
Net Income Growth
Outpacing revenue growth
Equity Growth
Retained earnings accumulating
Asset Growth
Sustainable expansion
Key Strengths
Competitive advantages to maintain
Exceptional Profitability
Gross margins (48.3%) and net margins (17.8%) significantly exceed industry averages, indicating strong pricing power and cost control.
Strong Liquidity Position
Current ratio of 2.80x and $2.45M in cash provides ample buffer for obligations and opportunities.
Low Leverage
D/E ratio of 0.51x is well below the industry average of 1.0x, reducing financial risk and interest burden.
Accelerating Revenue
Revenue growth accelerated from 11.8% to 14.2% YoY with diversified revenue streams across 4 segments.
Risk Factors
Areas requiring monitoring & mitigation
Inventory Days Increasing
DIO at 57.7 days is slightly high. Implement JIT strategies to reduce carrying costs by ~15%.
Rising Operating Costs
SG&A growth of 12.8% outpaced revenue growth in Q3. Needs monitoring for operating leverage.
Customer Concentration
Top 3 customers account for 28% of revenue. Diversification target: <20% by Q2 2026.
FX Exposure
EUR/GBP denominated revenue (~12%) exposed to currency fluctuation. Consider hedging strategy.
Recommended Actions
Strategic initiatives to improve business health
Optimize Inventory Management
Implement JIT procurement for top 20 SKUs to reduce DIO from 57.7 to 45 days, freeing ~$280K in working capital.
Hedging Strategy Implementation
Deploy forward contracts for 50% of projected EUR/GBP revenue exposure over next 3 quarters.
Customer Diversification Program
Allocate 15% of marketing budget to new customer acquisition in underpenetrated regions.
SG&A Optimization Review
Commission efficiency audit on G&A spend. Target: reduce growth rate to match revenue growth by Q3 2026.